R&F Capital Advisors’s Exelixis EXEL Stock Holding History

R&F Capital Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-24,742	Closed	-$369K	–	721
2016 Q4	$369K	Buy	+24,742	New	+$357K	0.13%	251

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

R&F Capital Advisors's EXEL Position: Q1 2017 in Review

R&F Capital Advisors sold out of Exelixis (EXEL) in Q1 2017, closing a stake of 24,742 shares — an estimated $369K sold.

R&F Capital Advisors first reported a position in EXEL in Q4 2016 and held it in 1 quarter. The position peaked at $369K in Q4 2016. 229 funds tracked by Wall St. Rank hold EXEL as of Q1 2017.

R&F Capital Advisors reported no remaining Exelixis position as of Q1 2017 after selling out during the quarter.
R&F Capital Advisors sold 24,742 Exelixis shares in Q1 2017, an estimated $369K.
R&F Capital Advisors first reported a position in Exelixis in Q4 2016 and held it in 1 quarter.
R&F Capital Advisors's Exelixis position peaked at $369K in Q4 2016.
229 funds tracked by Wall St. Rank held Exelixis as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.